Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 ()
ECCO'17 BarcelonaOP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Ustekinumab
Files: 1
ECCO'17 BarcelonaOP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with Ulcerative Colitis undergoing (procto)colectomy with ileal pouch- anal anastomosis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Ferrante M.
Ulcerative colitis, Ileo anal pouch procedure, Post operative complications, Post operative medical management, Vedolizumab
Files: 1
ECCO'17 BarcelonaOP013: Disease management and outcomes of patients with Crohn’s Disease at high risk of recurrence. Results from PRACTICROHN study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Iborra M.
Colonscopy, Ileo caecal resection, Post operative complications, Post operative medical management, Thiopurines ( AZA / MP )
Files: 1
ECCO'18 ViennaOP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Sazonovs Aleksejs
ECCO'17 BarcelonaOP014: Histological remission is predictive of improved clinical outcomes in patients with Ulcerative Colitis: Results from the TOUCHSTONE OLE
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Ozanimod, Histological remission
Files: 1
ECCO'17 BarcelonaOP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn’s Disease: THE LIR!C TRIAL
Year: 2017
Source: ECCO'17 Barcelona
Authors: de Groof J.
Crohn's disease, Ileo caecal resection, Laparoscopic surgery, Infliximab
Files: 1
ECCO'17 BarcelonaOP016: Potential role of bile acid receptor FXR in microscopic colitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Palmela C.
Histology, Microscopic colitis
Files: 1
ECCO'17 BarcelonaOP017: Telemedicine enables a safe shift from examination room based care to personalised care for Inflammatory Bowel Disease: A pragmatic randomised multicenter trial with myIBDcoach
Year: 2017
Source: ECCO'17 Barcelona
Authors: de Jong M.
Disease activity Indices, Patient reported outcomes, Quality of life, IBD nurse
Files: 1
ECCO'17 BarcelonaOP018: Optimal anti-TNF stop week during pregnancy depends on anti-TNF type
Year: 2017
Source: ECCO'17 Barcelona
Authors: Kanis S.
Anti TNF drug levels, Anti TNF agents, IBD in pregnancy
Files: 1
ECCO'17 BarcelonaOP020: Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Gils A.
Therapeutic drug monitoring, Pharmacokinetics, Vedolizumab
Files: 1
Page: () 1 2 3 4 5 6 7 8 9 10 ()